Ilika advances manufacturing readiness for solid-state batteries

Ilika Plc

UKBIC’s latest webinar with Ilika focused on a central issue for battery companies: how to turn promising technology into a product that can be manufactured at scale.

The session featured Andrew Britton, Business Development Manager at UKBIC, and Denis Pasero, Product Commercialisation Manager at Ilika. Their discussion centred on Ilika’s work with UKBIC to develop manufacturing capability for its Goliath pouch cell technology.

Commercial value depends on whether the technology can be made reliably, repeatedly and cost-effectively. That makes manufacturing validation a key milestone for companies developing next-generation batteries.

UKBIC, the UK’s national battery manufacturing development facility, helps companies move from laboratory development towards industrial production. Its facilities allow battery developers to test processes on equipment designed for larger-scale manufacturing. This gives companies a better understanding of how their technology may perform outside the lab and what issues need to be addressed before major capital is committed.

Ilika has used UKBIC’s facilities through its BUS100, SiSTEM and PRIMED programmes. This work has supported the development of manufacturing processes for the company’s Goliath pouch cell technology, with a focus on scale-up, process control and production readiness.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search